A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery

• Verfasst von: Antolovič, Dalibor [VerfasserIn]
• Verfasst von: Rakow, Anastasia [VerfasserIn]
• Verfasst von: Contin, Pietro [VerfasserIn]
• Verfasst von: Ulrich, Alexis [VerfasserIn]
• Verfasst von: Rahbari, Nuh Nabi [VerfasserIn]
• Verfasst von: Büchler, Markus W. [VerfasserIn]
• Verfasst von: Weitz, Jürgen [VerfasserIn]
• Verfasst von: Koch, Moritz [VerfasserIn]
• Titel: A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery
• Titelzusatz: the APAP trial (ISRCTN45810007)
• Verf.angabe: D. Antolovic, A. Rakow, P. Contin, A. Ulrich, N. N. Rahbari, M. W. Büchler, J. Weitz, M. Koch
• Jahr: 2012
• Jahr des Originals: 2011
• Umfang: 10 S.
• Fussnoten: Published online: 3 November 2011 ; Gesehen am 20.06.2018
• Titel Quelle: Enthalten in: Langenbeck's archives of surgery
• Ort Quelle: Berlin : Springer, 1948
• Jahr Quelle: 2012
• Band/Heft Quelle: 397(2012), 2, Seite 297-306
• ISSN Quelle: 1435-2451
• DOI: doi:10.1007/s00423-011-0867-7
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Adult
• Sach-SW: Aged
• Sach-SW: Aspirin
• Sach-SW: Blood Loss, Surgical
• Sach-SW: Cholecystectomy
• Sach-SW: Colorectal Surgery
• Sach-SW: Dose-Response Relationship, Drug
• Sach-SW: Drug Administration Schedule
• Sach-SW: Elective Surgical Procedures
• Sach-SW: Follow-Up Studies
• Sach-SW: Herniorrhaphy
• Sach-SW: Humans
• Sach-SW: Perioperative Care
• Sach-SW: Pilot Projects
• Sach-SW: Platelet Aggregation Inhibitors
• Sach-SW: Postoperative Hemorrhage
• Sach-SW: Reference Values
• Sach-SW: Risk Assessment
• Sach-SW: Surgical Procedures, Operative
• Sach-SW: Thromboembolism
• Sach-SW: Treatment Outcome
• K10plus-PPN: 1576571394

Abstract

PURPOSE: Surgeons are increasingly confronted by patients on long-term low-dose acetylsalicylic acid (ASA). However, owing to a lack of evidence-based data, a widely accepted consensus on the perioperative management of these patients in the setting of non-cardiac surgery has not yet been reached. Primary objective was to evaluate the safety of continuous versus discontinuous use of ASA in the perioperative period in elective general or abdominal surgery. METHODS: Fifty-two patients undergoing elective cholecystectomy, inguinal hernia repair or colonic/colorectal surgery were recruited to this pilot study. According to cardiological evaluation, non-high-risk patients who were on long-term treatment with low-dose ASA were eligible for inclusion. Patients were allocated randomly to continuous use of ASA or discontinuation of ASA intake for 5 days before until 5 days after surgery. The primary outcome was the incidence of major haemorrhagic and thromboembolic complications within 30 days after surgery. RESULTS: A total of 26 patients were allocated to each study group. One patient (3.8%) in the ASA continuation group required re-operation due to post-operative haemorrhage. In neither study group, further bleeding complications occurred. No clinically apparent thromboembolic events were reported in the ASA continuation and the ASA discontinuation group. Furthermore, there were no significant differences between both study groups in the secondary endpoints. CONCLUSIONS: Perioperative intake of ASA does not seem to influence the incidence of severe bleeding in non-high-risk patients undergoing elective general or abdominal surgery. Further, adequately powered trials are required to confirm the findings of this study.